What do systematic reviews say?

Total adverse events · people in remission or with mildly activeulcerative colitis

Total adverse events · people in remission or with mildly activeulcerative colitis

Total adverse events · people with mild‐to‐moderate disease (Rachmilewitz index) or active disease (SCCAI score of 4 to 10)

Total adverse events (6 months) · people with histologically confirmed diagnosis of ulcerative colitis in remission

Total adverse events · Patients with active mild to moderate ulcerative colitis

Total adverse events (9 weeks) · Patients with active mild to moderate ulcerative colitis